Attorneys Ask that Purdue Seek Political Contribution Permission
OxyContin manufacturer should be required to ask for judge’s permission before making political contributions, creditors contend.
Sara is a credited freelance writer, editor, contributor, and essayist, as well as a novelist and poet with nearly twenty years of experience. A seasoned publishing professional, she's worked for newspapers, magazines and book publishers in content digitization, editorial, acquisitions and intellectual property. Sara has been an invited speaker at a Careers in Publishing & Authorship event at Michigan State University and a Reading and Writing Instructor at Sylvan Learning Center. She has an MBA degree with a concentration in Marketing and an MA in Clinical Mental Health Counseling, graduating with a 4.2/4.0 GPA. She is also a member of Chi Sigma Iota and a 2020 recipient of the Donald D. Davis scholarship recognizing social responsibility. Sara is certified in children's book writing, HTML coding and social media marketing. Her fifth book, PTSD: Healing from the Inside Out, was released in September 2019 and is available on Amazon. You can find her others books there, too, including Narcissistic Abuse: A Survival Guide, released in December 2017.
OxyContin manufacturer should be required to ask for judge’s permission before making political contributions, creditors contend.
Brokers face charges in insurance fraud schemes.
Vermonters will need to keep their food scraps out of the trash with the passage of a new composting law.
Virginia is facing an unprecedented crisis as the coronavirus compounds its opioid issue.
The coronavirus is limiting access to treatment options addicts desperately need.
Pharmacies want physicians to be held accountable for prescribing addictive opioids.
A new NEJM study suggests supervised injection is a valid addiction treatment option.
Housing units help the homeless have a place to call home.
FSU forced to follow up with telecommute note after the university receives backlash from employees.
Drug development company is determined, despite second rejection, to get pain management drug approved.